pulmonologyadvisor15h
In COPD Treatment, Tezepelumab Not Linked to Reduced Exacerbations
Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.
Enumclaw Courier-Herald1d
Breathe Drops for Respiratory Relief Exposed: The Truth About Its Benefits for COPD and Asthma
In a world where respiratory issues are increasingly common, finding practical solutions can be daunting. Breathe Drops ...
COPD And Asthma Devices Market Is Likely To Expand USD 6.3 Billion At 12.6% CAGR By 2031
COPD-asthma-devices-market2025 PORTLAND, DE, UNITED STATES, January 29, 2025 /EINPresswire / -- Day-to-day exposure to environmental pollutio ...
Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust With 110+ Key Pharma Companies Actively Working In The Therapeutics Segment | Delveinsight
New York, USA, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust With 110+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...
Healio2d
Metered-dose to dry-powder inhaler switch not often reversed in veterans
A small proportion of veterans who went from a metered-dose inhaler to a dry-powder inhaler had to revert to the metered-dose ...